Your browser doesn't support javascript.
loading
The Landscape of Somatic Genetic Alterations in Breast Cancers From ATM Germline Mutation Carriers.
Weigelt, Britta; Bi, Rui; Kumar, Rahul; Blecua, Pedro; Mandelker, Diana L; Geyer, Felipe C; Pareja, Fresia; James, Paul A; Couch, Fergus J; Eccles, Diana M; Blows, Fiona; Pharoah, Paul; Li, Anqi; Selenica, Pier; Lim, Raymond S; Jayakumaran, Gowtham; Waddell, Nic; Shen, Ronglai; Norton, Larry; Wen, Hannah Y; Powell, Simon N; Riaz, Nadeem; Robson, Mark E; Reis-Filho, Jorge S; Chenevix-Trench, Georgia.
Affiliation
  • Weigelt B; Department of Pathology (BW, RB, RK, DLM, FCG, FP, AL, PS, RSL, GJ, HYW, JSRF) Memorial Sloan Kettering Cancer Center, New York, NY.
  • Bi R; Department of Pathology (BW, RB, RK, DLM, FCG, FP, AL, PS, RSL, GJ, HYW, JSRF) Memorial Sloan Kettering Cancer Center, New York, NY.
  • Kumar R; Department of Pathology, Fudan University Cancer Center, Shanghai, China (RB, AL).
  • Blecua P; Department of Pathology (BW, RB, RK, DLM, FCG, FP, AL, PS, RSL, GJ, HYW, JSRF) Memorial Sloan Kettering Cancer Center, New York, NY.
  • Mandelker DL; Radiation Oncology (PB, SNP, NR) Memorial Sloan Kettering Cancer Center, New York, NY.
  • Geyer FC; Department of Pathology (BW, RB, RK, DLM, FCG, FP, AL, PS, RSL, GJ, HYW, JSRF) Memorial Sloan Kettering Cancer Center, New York, NY.
  • Pareja F; Department of Pathology (BW, RB, RK, DLM, FCG, FP, AL, PS, RSL, GJ, HYW, JSRF) Memorial Sloan Kettering Cancer Center, New York, NY.
  • James PA; Department of Pathology (BW, RB, RK, DLM, FCG, FP, AL, PS, RSL, GJ, HYW, JSRF) Memorial Sloan Kettering Cancer Center, New York, NY.
  • Eccles DM; Department of Laboratory Medicine and Pathology, Mayo Clinic, Rochester, MN (FJC).
  • Blows F; Southampton Clinical Trials Unit, University of Southampton, Southampton, UK (DME).
  • Pharoah P; Department of Oncology, University of Cambridge, Cambridge, UK (FB, PP).
  • Li A; Department of Oncology, University of Cambridge, Cambridge, UK (FB, PP).
  • Selenica P; Department of Pathology (BW, RB, RK, DLM, FCG, FP, AL, PS, RSL, GJ, HYW, JSRF) Memorial Sloan Kettering Cancer Center, New York, NY.
  • Lim RS; Department of Pathology, Fudan University Cancer Center, Shanghai, China (RB, AL).
  • Jayakumaran G; Department of Pathology (BW, RB, RK, DLM, FCG, FP, AL, PS, RSL, GJ, HYW, JSRF) Memorial Sloan Kettering Cancer Center, New York, NY.
  • Waddell N; Department of Pathology (BW, RB, RK, DLM, FCG, FP, AL, PS, RSL, GJ, HYW, JSRF) Memorial Sloan Kettering Cancer Center, New York, NY.
  • Shen R; Department of Pathology (BW, RB, RK, DLM, FCG, FP, AL, PS, RSL, GJ, HYW, JSRF) Memorial Sloan Kettering Cancer Center, New York, NY.
  • Norton L; QIMR Berghofer Medical Research Institute, Brisbane, QLD, Australia (NW, GCT).
  • Wen HY; Epidemiology and Biostatistics (RS) Memorial Sloan Kettering Cancer Center, New York, NY.
  • Powell SN; Department of Medicine (LN, MER) Memorial Sloan Kettering Cancer Center, New York, NY.
  • Riaz N; Department of Pathology (BW, RB, RK, DLM, FCG, FP, AL, PS, RSL, GJ, HYW, JSRF) Memorial Sloan Kettering Cancer Center, New York, NY.
  • Robson ME; Radiation Oncology (PB, SNP, NR) Memorial Sloan Kettering Cancer Center, New York, NY.
  • Reis-Filho JS; Radiation Oncology (PB, SNP, NR) Memorial Sloan Kettering Cancer Center, New York, NY.
  • Chenevix-Trench G; Department of Medicine (LN, MER) Memorial Sloan Kettering Cancer Center, New York, NY.
J Natl Cancer Inst ; 110(9): 1030-1034, 2018 09 01.
Article in En | MEDLINE | ID: mdl-29506079
ABSTRACT
Pathogenic germline variants in ataxia-telangiectasia mutated (ATM), a gene that plays a role in DNA damage response and cell cycle checkpoints, confer an increased breast cancer (BC) risk. Here, we investigated the phenotypic characteristics and landscape of somatic genetic alterations in 24 BCs from ATM germline mutation carriers by whole-exome and targeted sequencing. ATM-associated BCs were consistently hormone receptor positive and largely displayed minimal immune infiltrate. Although 79.2% of these tumors exhibited loss of heterozygosity of the ATM wild-type allele, none displayed high activity of mutational signature 3 associated with defective homologous recombination DNA (HRD) repair. No TP53 mutations were found in the ATM-associated BCs. Analysis of an independent data set confirmed that germline ATM variants and TP53 somatic mutations are mutually exclusive. Our findings indicate that ATM-associated BCs often harbor bi-allelic inactivation of ATM, are phenotypically distinct from BRCA1/2-associated BCs, lack HRD-related mutational signatures, and that TP53 and ATM genetic alterations are likely epistatic.
Subject(s)

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Breast Neoplasms / Ataxia Telangiectasia Mutated Proteins / Heterozygote / Mutation Type of study: Diagnostic_studies / Prognostic_studies Limits: Adult / Aged / Female / Humans / Middle aged Language: En Journal: J Natl Cancer Inst Year: 2018 Type: Article

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Breast Neoplasms / Ataxia Telangiectasia Mutated Proteins / Heterozygote / Mutation Type of study: Diagnostic_studies / Prognostic_studies Limits: Adult / Aged / Female / Humans / Middle aged Language: En Journal: J Natl Cancer Inst Year: 2018 Type: Article